Computational pathology startup

FDA grants 'Breakthrough Device' designation to technologies that have the potential to provide more effective diagnosis

Computational pathology startup Paige.AI gets ‘Breakthrough Designation’ from FDA

The computational pathology startup Paige.AI has received 'Breakthrough Device' designation by the U.S. Food and Drug Administration (FDA)
- Advertisement -SAP Hana